Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Bacon

Showing results (231-240 of 250) with videos related to

Pageof 25
Sort By:
Leukemia|January 22, 2010
Variant IRF4/MUM1 associates with CD38 status and treatment-free survival in chronic lymphocytic leukaemiaJ M Allan, N J Sunter, J R Bailey, et al.
Bioorganic & Medicinal Chemistry Letters|June 25, 2019
Discovery of velpatasvir (GS-5816): A potent pan-genotypic HCV NS5A inhibitor in the single-tablet regimens Vosevi<sup>®</sup> and Epclusa<sup>®</sup>John O Link, James G Taylor, Alejandra Trejo-Martin, et al.
Bioorganic & Medicinal Chemistry Letters|March 31, 2012
Design, synthesis and structure-activity relationship of N-substituted tropane muscarinic acetylcholine receptor antagonistsDramane I Lainé, Hongxing Yan, Haibo Xie, et al.
Neuroimage|July 18, 2013
The current state-of-the-art of spinal cord imaging: applicationsC A Wheeler-Kingshott, P W Stroman, J M Schwab, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 6, 2003
Long-term follow-up confirms a survival advantage of the paclitaxel-cisplatin regimen over the cyclophosphamide-cisplatin combination in advanced ovarian cancerM J Piccart, K Bertelsen, G Stuart, et al.
Journal of the National Cancer Institute|May 4, 2000
Randomized intergroup trial of cisplatin-paclitaxel versus cisplatin-cyclophosphamide in women with advanced epithelial ovarian cancer: three-year resultsM J Piccart, K Bertelsen, K James, et al.
Blood|June 11, 2020
Germline TET2 loss of function causes childhood immunodeficiency and lymphomaJarmila Stremenova Spegarova, Dylan Lawless, Siti Mardhiana Binti Mohamad, et al.
Journal of Medicinal Chemistry|May 16, 2025
Discovery of Edecesertib (GS-5718): A Potent, Selective Inhibitor of IRAK4Stephen E Ammann, Jeromy J Cottell, Nathan E Wright, et al.
Blood|December 19, 2013
The evolution of cellular deficiency in GATA2 mutationRachel E Dickinson, Paul Milne, Laura Jardine, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 7, 2025
An aminosterol breaks the autocatalytic cycle of Aβ<sub>42</sub> aggregation and protects cell membranes from its soluble aggregatesLucas B Fallot, Johnathan R Pinc, Joseph E Buselmeier, et al.
Pageof 25

Showing results (231-240 of 250) with videos related to

Sort By:
Pageof 25
Leukemia|January 22, 2010
Variant IRF4/MUM1 associates with CD38 status and treatment-free survival in chronic lymphocytic leukaemiaJ M Allan, N J Sunter, J R Bailey, et al.
Bioorganic & Medicinal Chemistry Letters|June 25, 2019
Discovery of velpatasvir (GS-5816): A potent pan-genotypic HCV NS5A inhibitor in the single-tablet regimens Vosevi<sup>®</sup> and Epclusa<sup>®</sup>John O Link, James G Taylor, Alejandra Trejo-Martin, et al.
Bioorganic & Medicinal Chemistry Letters|March 31, 2012
Design, synthesis and structure-activity relationship of N-substituted tropane muscarinic acetylcholine receptor antagonistsDramane I Lainé, Hongxing Yan, Haibo Xie, et al.
Neuroimage|July 18, 2013
The current state-of-the-art of spinal cord imaging: applicationsC A Wheeler-Kingshott, P W Stroman, J M Schwab, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 6, 2003
Long-term follow-up confirms a survival advantage of the paclitaxel-cisplatin regimen over the cyclophosphamide-cisplatin combination in advanced ovarian cancerM J Piccart, K Bertelsen, G Stuart, et al.
Journal of the National Cancer Institute|May 4, 2000
Randomized intergroup trial of cisplatin-paclitaxel versus cisplatin-cyclophosphamide in women with advanced epithelial ovarian cancer: three-year resultsM J Piccart, K Bertelsen, K James, et al.
Blood|June 11, 2020
Germline TET2 loss of function causes childhood immunodeficiency and lymphomaJarmila Stremenova Spegarova, Dylan Lawless, Siti Mardhiana Binti Mohamad, et al.
Journal of Medicinal Chemistry|May 16, 2025
Discovery of Edecesertib (GS-5718): A Potent, Selective Inhibitor of IRAK4Stephen E Ammann, Jeromy J Cottell, Nathan E Wright, et al.
Blood|December 19, 2013
The evolution of cellular deficiency in GATA2 mutationRachel E Dickinson, Paul Milne, Laura Jardine, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 7, 2025
An aminosterol breaks the autocatalytic cycle of Aβ<sub>42</sub> aggregation and protects cell membranes from its soluble aggregatesLucas B Fallot, Johnathan R Pinc, Joseph E Buselmeier, et al.
Pageof 25